Free Trial

Orbis Allan Gray Ltd Decreases Holdings in Genpact Limited $G

Genpact logo with Computer and Technology background

Key Points

  • Orbis Allan Gray Ltd reduced its stake in Genpact by 16.7%, selling 302,065 shares and bringing its total holdings to approximately 1.5 million shares, valued at $75.9 million.
  • Several institutional investors, including Envestnet Portfolio Solutions Inc. and GAMMA Investing LLC, increased their stakes in Genpact, indicating growing interest among hedge funds.
  • Genpact announced a quarterly dividend of $0.17, reflecting an annualized yield of 1.5%, with the next dividend payout scheduled for September 25th.
  • Five stocks we like better than Genpact.

Orbis Allan Gray Ltd reduced its position in shares of Genpact Limited (NYSE:G - Free Report) by 16.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,506,477 shares of the business services provider's stock after selling 302,065 shares during the period. Orbis Allan Gray Ltd owned about 0.86% of Genpact worth $75,896,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Envestnet Portfolio Solutions Inc. boosted its holdings in Genpact by 59.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after purchasing an additional 3,849 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Genpact by 20.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after purchasing an additional 1,651 shares during the period. GAMMA Investing LLC boosted its holdings in Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after purchasing an additional 4,561 shares during the period. 111 Capital purchased a new position in Genpact in the fourth quarter valued at $301,000. Finally, Assenagon Asset Management S.A. purchased a new position in Genpact in the first quarter valued at $2,396,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on G shares. Deutsche Bank Aktiengesellschaft started coverage on Genpact in a research note on Thursday, July 17th. They issued a "hold" rating and a $47.00 price target on the stock. Mizuho raised their price target on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. JPMorgan Chase & Co. lowered their price target on Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a report on Wednesday, August 20th. Needham & Company LLC raised their price target on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Finally, Robert W. Baird lowered their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Genpact has a consensus rating of "Hold" and an average target price of $52.29.

View Our Latest Stock Report on Genpact

Genpact Stock Performance

G traded up $0.23 during trading on Wednesday, reaching $45.12. The company's stock had a trading volume of 2,235,683 shares, compared to its average volume of 1,626,142. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76. The company's fifty day moving average price is $44.47 and its 200-day moving average price is $46.41. The company has a market capitalization of $7.86 billion, a price-to-earnings ratio of 14.99, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, topping the consensus estimate of $0.85 by $0.03. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, equities analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.5%. Genpact's payout ratio is 22.59%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines